Nature vs Science vs Cell, Compared by the Numbers and by Editorial Style

If you are looking for a clean ordinal ranking, the data will disappoint you.

Nature leads slightly on impact factor. Science is slightly lower. Cell is slightly lower again. But the distance between 48.5, 45.8, and 42.5 is not the strategic story.

The strategic story is how each journal converts prestige into editorial behavior.

Nature's own editorial-criteria page says only about 8% of submitted manuscripts are accepted and that most submissions are declined without peer review. The same page makes clear that editors, not referees, make the central judgment about broad readership and significance.

That means Nature is the strongest editor-led filter of the three in practical terms.

Science's tracked data shows the lowest headline acceptance signal of the three, at under 7%, with desk rejection around 75%. Its research-article format is also materially shorter than Cell's typical narrative style, which changes what kinds of papers feel native there.

Cell's tracked impact factor is 42.5, with a desk-rejection signal around 65%, and a process that tends to tolerate more mechanistic density than either Nature or Science. The journal is not softer. It is narrower and more specialist.

That distinction is everything.

Nature is the most multidisciplinary and the most dependent on generalist editorial taste.

Its editorial criteria page says papers should be of outstanding scientific importance and of interest to researchers across disciplines. It also says editors look for results that are novel, arresting, and have immediate and far-reaching implications.

In practice, that means Nature is asking:

• does this result change how a broad scientific audience thinks?
• can a smart scientist outside the narrow subfield understand why it matters?
• does this feel bigger than a specialist advance?

That is why Nature produces so many fast rejections. A paper can be technically excellent and still fail the "broad significance" test in the first few minutes.

Nature is the wrong first choice when:

• the work is excellent but legible only to specialists
• the mechanistic depth matters more than the broad claim
• the story needs a field-trained audience to appreciate its significance

Science is also a broad journal, but it often rewards a slightly different shape of manuscript.

The tracked dataset flags:

• a very low overall acceptance signal, under 7%
• a high desk rejection rate, around 75%
• a shorter first-decision cycle than most specialty journals, about 14 days
• a 3,000-word research-article limit in the current tracked notes

That combination tells you something important: Science likes a tight, decisive story.

This is often a better home than Cell for papers that:

• make one clean point very well
• have broad implications without requiring a long mechanistic build-out
• connect clearly to health, technology, environment, or policy conversation

Science can also be friendlier than Nature to a manuscript that is broad and important but does not need a huge multi-figure architecture.

Cell should not be treated as "Nature or Science, but for biologists." That framing is too crude.

Cell is better understood as the place where mechanistic biological stories are allowed to be fully themselves.

The tracked notes emphasize:

• about 8,000 submissions per year
• desk rejection around 65%
• median review time around 40 days
• papers often carrying 7 to 8 main figures plus extensive supplements

That is an editorial fingerprint. Cell is telling you it is willing to handle longer, denser, more specialist stories if the biology is strong enough.

This is why Cell is often the best of the three for:

• molecular and cell biology
• mechanistic immunology
• signaling, regulation, organelle, metabolism, and systems-biology stories
• manuscripts where reviewers will care deeply about causal completeness

Nature may want the conceptual headline. Cell wants the full mechanistic case.

This is why a Cell paper can be stronger than a Science paper for one project and weaker for another. The comparison is manuscript-shaped, not brand-shaped.

The biggest mistake is aiming in prestige order instead of fit order.

A lot of labs still do some version of:

1. try Nature
2. then Science
3. then Cell

That sequence makes no sense for a manuscript whose true native home is Cell. It can cost months.

If the work is:

• broad, conceptual, cross-disciplinary: start with Nature
• broad, clean, and high-impact but more concise: start with Science
• specialist but top-tier mechanistic biology: start with Cell

The wrong order is not harmless. It burns time and morale, and it often produces rejections that were predictable from the abstract alone.

Nature has the fastest tracked first-decision signal here at 7 days median, but authors should not confuse that with a faster path to publication.

Nature's tracked notes also show a median submission-to-acceptance time of 324 days. That is a reminder that:

• fast desk triage does not mean easy publication
• once a paper is in review, the process can still be long and demanding

Cell's tracked median review time around 40 days and its heavier-figure culture tell a different story: slower initial depth, but often with a manuscript already shaped for a specialist conversation.

Science sits between the two. Its concise format can streamline the story, but only if the paper naturally fits that format.

If timeline matters, do not read a single timing metric in isolation. Use average review times across 100 journals alongside journal-specific fit.

This is the easiest place to feel the editorial differences.

You need a statement that makes a general scientist stop. If the significance appears only after field-specific context, Nature becomes less likely.

You need a punchy, elegant, forward-driving narrative. The paper should feel like one clear discovery, not an overbuilt case file.

You can be more biologically specific, but the abstract still needs to make the mechanism and its significance obvious. Reviewers will tolerate density if the payoff is real.

Choose the journal whose rejection reasons are least likely to apply to your paper.

That sounds obvious, but it is a better rule than "choose the highest brand."

Use this quick filter:

• if your paper needs non-specialists to care immediately, think Nature or Science
• if your paper is strongest when read by biological specialists, think Cell
• if the core win is a big conceptual principle, lean Nature
• if the core win is a concise, high-impact finding, lean Science
• if the core win is a complete mechanistic system, lean Cell

For a less metric-heavy version of this question, see the existing Nature vs Science vs Cell guide. For general submission calibration, compare with the desk rejection report before you commit.